Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method

A. Tripodi, M. Poggio, L. Scapellato, P. M. Mannucci

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We report studies of the validity and clinical application of a new amidolytic method for evaluating the activated partial thromboplastin time (APTT) compared with a conventional clotting method. The results with the two methods were well correlated for normal plasma and plasma from hemophilia patients. Congenital deficiencies of the intrinsic coagulation pathway other than hypo and dysfibrinogenemia detected by the amidolytic method agreed with those detected by the clotting APTT. The results with the two methods for plasma from patients under heparin treatment were statistically different, suggesting a lesser sensitivity of the amidolytic method to heparinization. The use of the amidolytic APTT reagent in combination with factor VIII and IX deficient plasma allowed the measurement of both factors. The results obtained with normal and hemophilic plasma were in agreement with those obtained with the one-stage clotting method in all except two occasions. Even though the amidolytic method demonstrated the presence of the lupus anticoagulant in the majority of tested samples of known lupus subjects, it was less sensitive to the abnormality than the clotting method.

Original languageEnglish
Pages (from-to)205-212
Number of pages8
JournalPathophysiology of Haemostasis and Thrombosis
Volume19
Issue number4
DOIs
Publication statusPublished - 1989

Fingerprint

Partial Thromboplastin Time
Lupus Coagulation Inhibitor
Factor IX
Factor VIII
Hemophilia A
Heparin

Keywords

  • Activated partial thromboplastin time
  • Centrifugal analyzer
  • Chromogenic substrates
  • Hemostasis screening

ASJC Scopus subject areas

  • Hematology
  • Physiology (medical)

Cite this

@article{3eb0405aca3b4931bf5550f4e8606b6c,
title = "Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method",
abstract = "We report studies of the validity and clinical application of a new amidolytic method for evaluating the activated partial thromboplastin time (APTT) compared with a conventional clotting method. The results with the two methods were well correlated for normal plasma and plasma from hemophilia patients. Congenital deficiencies of the intrinsic coagulation pathway other than hypo and dysfibrinogenemia detected by the amidolytic method agreed with those detected by the clotting APTT. The results with the two methods for plasma from patients under heparin treatment were statistically different, suggesting a lesser sensitivity of the amidolytic method to heparinization. The use of the amidolytic APTT reagent in combination with factor VIII and IX deficient plasma allowed the measurement of both factors. The results obtained with normal and hemophilic plasma were in agreement with those obtained with the one-stage clotting method in all except two occasions. Even though the amidolytic method demonstrated the presence of the lupus anticoagulant in the majority of tested samples of known lupus subjects, it was less sensitive to the abnormality than the clotting method.",
keywords = "Activated partial thromboplastin time, Centrifugal analyzer, Chromogenic substrates, Hemostasis screening",
author = "A. Tripodi and M. Poggio and L. Scapellato and Mannucci, {P. M.}",
year = "1989",
doi = "10.1159/000215918",
language = "English",
volume = "19",
pages = "205--212",
journal = "Pathophysiology of Haemostasis and Thrombosis",
issn = "1424-8832",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method

AU - Tripodi, A.

AU - Poggio, M.

AU - Scapellato, L.

AU - Mannucci, P. M.

PY - 1989

Y1 - 1989

N2 - We report studies of the validity and clinical application of a new amidolytic method for evaluating the activated partial thromboplastin time (APTT) compared with a conventional clotting method. The results with the two methods were well correlated for normal plasma and plasma from hemophilia patients. Congenital deficiencies of the intrinsic coagulation pathway other than hypo and dysfibrinogenemia detected by the amidolytic method agreed with those detected by the clotting APTT. The results with the two methods for plasma from patients under heparin treatment were statistically different, suggesting a lesser sensitivity of the amidolytic method to heparinization. The use of the amidolytic APTT reagent in combination with factor VIII and IX deficient plasma allowed the measurement of both factors. The results obtained with normal and hemophilic plasma were in agreement with those obtained with the one-stage clotting method in all except two occasions. Even though the amidolytic method demonstrated the presence of the lupus anticoagulant in the majority of tested samples of known lupus subjects, it was less sensitive to the abnormality than the clotting method.

AB - We report studies of the validity and clinical application of a new amidolytic method for evaluating the activated partial thromboplastin time (APTT) compared with a conventional clotting method. The results with the two methods were well correlated for normal plasma and plasma from hemophilia patients. Congenital deficiencies of the intrinsic coagulation pathway other than hypo and dysfibrinogenemia detected by the amidolytic method agreed with those detected by the clotting APTT. The results with the two methods for plasma from patients under heparin treatment were statistically different, suggesting a lesser sensitivity of the amidolytic method to heparinization. The use of the amidolytic APTT reagent in combination with factor VIII and IX deficient plasma allowed the measurement of both factors. The results obtained with normal and hemophilic plasma were in agreement with those obtained with the one-stage clotting method in all except two occasions. Even though the amidolytic method demonstrated the presence of the lupus anticoagulant in the majority of tested samples of known lupus subjects, it was less sensitive to the abnormality than the clotting method.

KW - Activated partial thromboplastin time

KW - Centrifugal analyzer

KW - Chromogenic substrates

KW - Hemostasis screening

UR - http://www.scopus.com/inward/record.url?scp=0024340866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024340866&partnerID=8YFLogxK

U2 - 10.1159/000215918

DO - 10.1159/000215918

M3 - Article

C2 - 2509308

AN - SCOPUS:0024340866

VL - 19

SP - 205

EP - 212

JO - Pathophysiology of Haemostasis and Thrombosis

JF - Pathophysiology of Haemostasis and Thrombosis

SN - 1424-8832

IS - 4

ER -